MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 13.01.2026
Bio-Path Holdings P/B 2011-2026 | BPTH
P/B Jährlich Bio-Path Holdings
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.67 | 0.0406 | 0.991 | 1.01 | 0.805 | 0.99 | 2.87 | 10.5 | 12.8 | 13.5 | 65 | 10 | 4.62 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 65 | 0.0406 | 9.99 |
P/B anderer Aktien in der Pharmaeinzelhändler
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M |  Germany |
 |
Aligos Therapeutics
ALGS
|
1.23 | $ 8.71 | -0.11 % | $ 86.1 M |  USA |
 |
Allakos
ALLK
|
0.674 | - | - | $ 28.6 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
125 | $ 3.6 | -1.64 % | $ 8.66 B |  Australia |
 |
Aptinyx
APTX
|
0.248 | - | -39.0 % | $ 4.57 M | USA |
 |
Aravive
ARAV
|
5.67 | - | -13.39 % | $ 1.45 M | USA |
 |
Anavex Life Sciences Corp.
AVXL
|
3.07 | $ 3.29 | 5.63 % | $ 281 M | USA |
 |
I-Mab
IMAB
|
1.12 | - | - | $ 866 M |  China |
 |
AlloVir
ALVR
|
-0.258 | - | 4.14 % | $ 49.1 M | USA |
 |
Applied Molecular Transport
AMTI
|
0.364 | - | - | $ 10.1 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
596 | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M | France |
 |
Brainstorm Cell Therapeutics
BCLI
|
-0.815 | - | -2.5 % | $ 5.88 M | USA |
 |
Applied Therapeutics
APLT
|
-31.5 | - | - | $ 8.42 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | USA |
 |
BeiGene, Ltd.
BGNE
|
75.9 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
BioNTech SE
BNTX
|
5.29 | $ 99.62 | 3.02 % | $ 27.2 B | Germany |
 |
bluebird bio
BLUE
|
0.344 | - | - | $ 546 M | USA |
 |
Burford Capital Limited
BUR
|
1.26 | $ 4.74 | 5.46 % | $ 746 M |  Britain |
 |
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M | Britain |
 |
Cabaletta Bio
CABA
|
2.53 | $ 3.26 | 1.72 % | $ 328 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.58 | $ 21.51 | 0.7 % | $ 1.01 B | USA |
 |
Checkpoint Therapeutics
CKPT
|
-12.7 | - | - | $ 169 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - |  Russia |
 |
Adverum Biotechnologies
ADVM
|
1.08 | - | - | $ 86.2 M | USA |
 |
Advaxis
ADXS
|
0.113 | - | -9.65 % | $ 45.9 M | USA |
 |
Clearside Biomedical
CLSD
|
-6.37 | - | - | $ 25.3 M | USA |
 |
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M |  Canada |
 |
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | USA |
 |
Akebia Therapeutics
AKBA
|
10.3 | $ 1.55 | 5.1 % | $ 399 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.382 | - | - | $ 26.5 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
32 | $ 3.05 | 4.45 % | $ 5.02 M |  Israel |
 |
Aquestive Therapeutics
AQST
|
-13.9 | $ 4.21 | 0.48 % | $ 450 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
18.2 | $ 25.28 | 4.79 % | $ 3.22 B | USA |
 |
Chimerix
CMRX
|
0.537 | - | - | $ 756 M | USA |
 |
Concert Pharmaceuticals
CNCE
|
0.92 | - | - | $ 401 M | USA |
 |
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | USA |
 |
Celldex Therapeutics
CLDX
|
3.87 | $ 33.61 | 3.13 % | $ 2.23 B | USA |
 |
Autolus Therapeutics plc
AUTL
|
1.81 | $ 1.51 | 2.44 % | $ 402 M | Britain |
 |
Aptose Biosciences
APTO
|
-0.511 | - | -45.71 % | $ 1.2 M | Canada |
 |
Cidara Therapeutics
CDTX
|
0.908 | - | - | $ 1.41 B | USA |
 |
AVROBIO
AVRO
|
0.594 | - | 1083.1 % | $ 745 M | USA |
 |
CNS Pharmaceuticals
CNSP
|
0.234 | $ 2.46 | -2.19 % | $ 1.09 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M | Israel |
 |
AstraZeneca PLC
AZN
|
2.07 | - | - | $ 96.9 B | Britain |
 |
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | USA |
 |
CTI BioPharma Corp.
CTIC
|
-31.3 | - | - | $ 1.2 B | USA |
 |
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M | Germany |